Prostatic growth factor

Details Prostatic growth factor Prostatic growth factor

2007-02-23

2010-06-22

Stucker, Jeffrey (Department: 1649)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007200, C436S501000, C436S512000

Reexamination Certificate

active

07741055

ABSTRACT:
The present invention relates to human PGF polypeptides and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques, and antibodies and antagonist/inhibitors against such polypeptides. Also provided are methods of using such polypeptides therapeutically for treating prostate cancer, to promote tissue regeneration and to facilitate wound healing. Also provided is a diagnostic assay to detect prostate cancer and benign prostatic hyperplasia.

REFERENCES:
patent: 4931548 (1990-06-01), Lucas et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5168051 (1992-12-01), Derynck et al.
patent: 5221620 (1993-06-01), Purchio et al.
patent: 5223408 (1993-06-01), Goeddel et al.
patent: 5332669 (1994-07-01), Deuel
patent: 5366875 (1994-11-01), Wozney et al.
patent: 5994102 (1999-11-01), Hudson et al.
patent: 6500638 (2002-12-01), Hudson et al.
patent: 6521227 (2003-02-01), Hudson et al.
patent: 6680372 (2004-01-01), Lee et al.
patent: 7282351 (2007-10-01), Hudson et al.
patent: 7-250688 (1995-10-01), None
patent: 7-258293 (1995-10-01), None
patent: WO-97/00958 (1997-01-01), None
patent: WO-97/36926 (1997-10-01), None
patent: WO-98/11224 (1998-03-01), None
Bottner et al. Cell Tissue Res., 1999, vol. 297, pp. 103-110.
U.S. Appl. No. 09/912,293, Rosen et al.
U.S. Appl. No. 09/912,292, Rosen et al.
Anscher et al.,The New England Journal of Medicine, 328(22):1592-1598 (1993).
Bauskin et al., “The propeptide of macrophage inhibitory cytokine (MIC-1), a TGR-β superfamily member, acts as a quality control determinant for correctly folded MIC-1”EMBO J. 19(10):2212-2220 (2000).
Bootcov et al., “MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily,”Proc. Natl. Acad. Sci. USA94:11514-11519 (Oct. 1997).
Böttner et al., “Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1).”Gene, 237:105-111 (1999).
Buckhaults et al., “Secreted and cell surface genes expressed in benign and malignant colorectal tumors,”Cancer Res., 61:6996-7001 (Oct. 1, 2001).
Fairlie et al., “Epitope mapping of the transforming growth factor-β superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): Identification of at least five distinct epitope specificities,”Biochem., 40:65-73 (2001).
Fairlie et al., “MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation,”J. Leuk. Bio., 65:2-5 (Jan. 1999).
Fairlie et al., “The propeptide of the transforming growth factor-β superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion,”J. Biol. Chem., 276(20):16911-16918 (May 18, 2000).
Genbank Accession No. NP—004855, “Prostate differentiation factor; PTGF-beta [Homo sapiens],” May 26, 2001.
Genbank Accession No. NM—004864, “Homo sapiensprostate differentiation factor (PLAB), mRNA,” May 26, 2001.
Geneseq Accession No. R07335 (1991).
George et al., Macromolecular Sequencing & Synth., 127-149 (1988).
Kingsley, “The TGFβ superfamily: new members, new receptors, and genetic tests of function in different organisms,”Gene&Development, 8:133-146 (1994).
Lawton et al., “Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta,”Gene, 203:17-26 (1997).
Li et al., “Placental transforming growth factor-β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression,”J. Biol. Chem., 275 (26), 20127-20135 (2000).
Lin et al.,Cell, 68:775-785 (1992).
Massague, “The TGF-β Family of Growth and Differentiation Factors,”Cell, 49:437-438 (1987).
Paralkar et al., “Cloning and characterization of a novel member of the transforming growth factor-β/bone morphogenetic protein family”,J. Biol. Chem., 273 (22), 13760-13767 (1998).
Welsh et al., “Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer,”Cancer Res., 61:5974-5978 (Aug. 15, 2001).
Yokoyama-Kobayashi et al., “Human cDNA encoding a novel TGF-β superfamily protein highly expressed in placenta,”J. Biochem., 122:622-626 (1997).
Abaza et al., “Effects of Amino Acid Substitutions Outside an Antigenic Site on Protein Binding to Monoclonal Antibodies of Predetermined Specificity Obtained by Peptide Immunization: Demonstration with Region 94-100 (Antigenic Site 3) of Myoglobin,”J. Protein Chem., 11(5):433-444 (1992).
Colman, P.M., “Effects of amino acid sequence changes on antibody-antigen interactions,”Research in Immunology, 145(1):33-36 (1994).
Lederman et al., “A Single Amino Acid Substitution In a Common African Allele of the CD4 Molecule Ablates Binding of the Monoclonal Antibody, OKT4,”Molecular Immunology, 28:1171-1181 (1991).
Li et al., “β-Endorphin omission analogs: Dissociation of immunoreactivity from other biological activities,”Proc. Natl. Acad. Sci. USA, 77(6):3211-3214 (1980).
Mikayama et al., “Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor,”Proc. Natl. Acad. Sci. USA, 90:10056-10060 (1993).
Ngo et al. in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al., (ed), Birkhauser, Boston, MA, pp. 433 and 492-495 (1994).
International Search Report mailed on May 4, 1995, in connection with International Application No. PCT/US94/14578.

Affiliated with

Also associated with

Rating

Prostatic growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostatic growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostatic growth factor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4207396